ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference PR Newswire LAUSANNE, Switzerland, Sept. 3, 2026 LAUSANNE, Switzerland ...
Humabs BioMed Competitors or Alternatives
Humabs BioMed's top competitors include ADC Therapeutics, Kymab and OBT.
Humabs BioMed VS ADC Therapeutics
ADC Therapeutics is perceived as one of Humabs BioMed's biggest rivals. ADC Therapeutics's headquarters is in Epalinges, Vaud, and was founded in 2011. ADC Therapeutics operates in the Biotechnology industry. ADC Therapeutics generates 994% of Humabs BioMed's revenue.
Looking for similar companies to Humabs BioMed?
Similar Companies
Biotechnology companies in Ticino
See 11 companies
Companies in Ticino with employees in 250-500 rangeSee 23 companies
Pharmaceuticals & Biotechnology companies in TicinoSee 34 companies
Companies in Ticino with revenue in $5.0-25M rangeSee 74 companies
Biotechnology companies with employees in 250-500 rangeSee 343 companies
Companies in Switzerland with employees in 250-500 rangeSee 383 companies
Biotechnology companies in SwitzerlandSee 408 companies
Pharmaceuticals & Biotechnology companies with employees in 250-500 rangeSee 683 companies
Pharmaceuticals & Biotechnology companies in SwitzerlandSee 797 companies
Trending News for Humabs BioMed and Humabs BioMed's Competitors
NORTH CHICAGO, Ill. , Sept. 3, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference...
New relationship reflects Ark Clinical Research's continued commitment to expanding access to inclusive clinical trials. Ark Clinical Research is pleas...
Astellas Pharma Inc, a major Japanese global drug and life sciences company committed to turning innovative science into value for patients, announced ...
The co-development deal comes after Pfizer reported a late-stage failure for a Seagen asset and the discontinuation of another investigational therapy ...
Regeneron Pharmaceuticals stock hits 52-week high at $847.60...
The completion of the Apogee acquisition is an important step in further strengthening AbbVie's leadership in immunology and advancing our long-term gr...
AbbVie reports positive Phase 3 results for etentamig, showing higher response rates and improved survival in multiple myeloma patients.read more...
AbbVie's Skyrizi, Rinvoq and neuroscience drugs drive growth, but Humira erosion, oncology and Aesthetics remain key headwinds....
Pfizer, working with Omnicom Health Hong Kong, has launched a migraine awareness initiative that meets busy affluent Hon......
Frequently Asked Questions about Humabs BioMed
Who are Humabs BioMed's top competitors?
Humabs BioMed's top 3 competitors are ADC Therapeutics, Kymab, OBT.Who is similar to Humabs BioMed?
ADC Therapeutics is the most similar to Humabs BioMed. Kymab and OBT are also similar to Humabs BioMed.
Are Humabs BioMed and ADC Therapeutics competitors?
Yes, ADC Therapeutics is one of Humabs BioMed’s top competitors.